Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Conditions
- Acute Biphenotypic Leukemia
- de Novo Myelodysplastic Syndrome
- Previously Treated Myelodysplastic Syndrome
- Recurrent Adult Acute Myeloid Leukemia
- Untreated Adult Acute Myeloid Leukemia
- Secondary Acute Myeloid Leukemia
Interventions
- DRUG: Cladribine
- DRUG: Cytarabine
- BIOLOGICAL: Filgrastim
- OTHER: Laboratory Biomarker Analysis
- DRUG: Mitoxantrone Hydrochloride
Sponsor
Fred Hutchinson Cancer Center
Collaborators